Exploring the novel duo of Reticulocalbin, and Sideroflexin as future biomarker candidates for Exacerbated Chronic Obstructive Pulmonary Disease.
Sonu DasSupriya AdiodyJinsu VargheseM VandithaEvelyn MariaMathew John
Published in: Clinical proteomics (2024)
Our study discovered a novel duo of proteins reticulocalbin-1, and sideroflexin-4 that showed potential as valuable future biomarkers for the diagnosis and clinical management of COPD exacerbations.